Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015

Cost and committee reports

Official records Congress.gov attaches to H.R. 1807.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. DANNY K. DAVIS of Illinois, as printed in the Congressional Record (Vol. 161, No. 54, April 15, 2015, Page H2269):
  This bill is enacted pursuant to the power granted to Congress under Article I of the United States Constitution and its subsequent amendments, and further clarified and interpreted by the Supreme Court of the United States
  Source: Congress.gov, Congressional Record April 15, 2015 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  223 characters

  Congress.gov bill record

  H.R. 1807, 114th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/114/hr/1807

  Record last updated by Congress.gov

  August 12, 2025

  PORKER copy retrieved

  September 22, 2026

  Stored copy, SHA-256 of the file

  94bb86b87b2b1dfcc7f736b63122d36f15821c7f7e25ab30904dc40c21f38fce

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of August 12, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 1807, last updated August 12, 2025. PORKER’s copy was retrieved September 22, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.